FOXP3 and COVID-19: Additionally, recent research found that patients with COVID-19 had higher proportions of Tregs (characterized by the presence of CD3+ CD4+ CD25+ markers) and higher levels of FoxP3 expression by Tregs, which were associated with a poor prognosis of the disease [20].